Free

CHEP+ CV Risk Reduction in Diabetes - Mar 4th, 2021 7pm ET

Actions and Detail Panel

Free

Event Information

Share this event

Date and Time

Location

Location

Online Event

Event description
CV Risk Reduction in Diabetes (SGLT2 inhibitors/GLP-1 Receptor Agonists in Patients with DM, CVD)- Mar 4th, 7PM ET

About this Event

CHEP+ Clinical Practice Guidelines Program

CV Risk Reduction in Diabetes (SGLT2 inhibitors/GLP-1 Receptor Agonists in Patients with DM and CVD)

Thursday, March 4th, 2021 • 7 PM - 9 PM (ET)

Presented By: Jeff Habert, MD, CCFP, FCFP

Dr. Habert is an Assistant Professor in the Department of Family and Community Medicine at the University of Toronto, Co-Chair of the Clinical Practice Guidelines Committee Thrombosis Canada.

LEARNING OBJECTIVES

Upon completion of this case study, participants should be able to:

  • Describe the patient who should be treated with an SGLT2i or GLP-1 RA
  • Explain the rationale for this treatment and the potential benefits
  • Describe the steps for initiating and monitoring therapy for patients with diabetes

Accreditation: This Group Learning program has been certified by the Canadian College of Family Physicians for up to 6 Mainpro+ credits for the 2-hour presentation including a practice reflection survey to be completed at 6 weeks post-session.

You will receive an email before the event with the details on how to join Online.

This session was made possible through an educational grant from Eli Lilly Canada Inc.

FAQs

• How can I contact the organizer with any questions? To contact the organizer, email: Diane Hua-Stewart at Diane.Hua@sunnybrook.ca / (416) 710-3892.

• To learn more: Please visit www.chepplus.com


		CHEP+ CV Risk Reduction in Diabetes  - Mar 4th, 2021 7pm ET image
Share with friends

Date and Time

Location

Online Event

Save This Event

Event Saved